title: Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
authors.affiliation: National Center for Emerging and Zoonotic Infectious Diseases (proposed), CDC, Atlanta, GA 30333, USA. cyr5@cdc.gov
authors.forename: Charles E
authors.initials: CE
authors.lastname: Rupprecht
authors.forename: Deborah
authors.initials: D
authors.lastname: Briggs
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Brown
authors.forename: Richard
authors.initials: R
authors.lastname: Franka
authors.forename: Samuel L
authors.initials: SL
authors.lastname: Katz
authors.forename: Harry D
authors.initials: HD
authors.lastname: Kerr
authors.forename: Susan M
authors.initials: SM
authors.lastname: Lett
authors.forename: Robin
authors.initials: R
authors.lastname: Levis
authors.forename: Martin I
authors.initials: MI
authors.lastname: Meltzer
authors.forename: William
authors.initials: W
authors.lastname: Schaffner
authors.forename: Paul R
authors.initials: PR
authors.lastname: Cieslak
mesh_terms: D006801:Humans; D007115:Immunization Schedule; D007121:Immunocompetence; D007136:Immunoglobulins / Q000627:therapeutic use; D007273:Injections, Intramuscular; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D011820:Rabies virus / Q000276:immunology / Q000472:pathogenicity
chemical_list: D007136:Immunoglobulins; D011819:Rabies Vaccines